title: Assessing the impact of HBV NAT on window period reduction and residual risk.
authors.affiliation: Kleinman BioMedical Consulting, Victoria, BC, Canada.
authors.forename: Steven H
authors.initials: SH
authors.lastname: Kleinman
authors.forename: Michael P
authors.initials: MP
authors.lastname: Busch
mesh_terms: D006509:Hepatitis B / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission*; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D021141:Nucleic Acid Amplification Techniques; D012307:Risk Factors